Table 2. Cochlear Implant (CI)-Related Characteristics of Focus Group Participants.
| Group 1 (n = 4) |
Group 2 (n = 9) |
Group 3 (n = 10) |
Total (N = 23) |
|
|---|---|---|---|---|
| Best aided consonant–vowel nucleus–consonant word scores, % | ||||
| Mean (SD) | 20.5 (13.9) | 58.4 (5.3) | 77.6 (10.4) | 61.0 (22.9) |
| Range | 0-30 | 48-66 | 68-96 | 0-96 |
| Listening modality, No. (%) | ||||
| Unilateral CI (not bimodal) | 2 (50) | 1 (11) | 0 | 3 (13) |
| Bimodala | 1 (25) | 3 (33) | 2 (20) | 6 (26) |
| Bilateral CI | 1 (25) | 5 (56) | 8 (80) | 14 (61) |
| Electroacoustic listeningb | 0 | 0 | 2 (20) | 2 (9) |
| Device manufacturer, No. (%) | ||||
| Advanced Bionics | 1 (25) | 4 (44) | 3 (30) | 8 (35) |
| Cochlear | 2 (50) | 3 (33) | 5 (50) | 10 (43) |
| MED-EL | 1 (25) | 2 (22) | 2 (20) | 5 (22) |
| Duration of CI use, mean (SD), y | 7.7 (5.2) | 4.8 (4.1) | 4.6 (1.9) | 5.2 (3.4) |
| Age at CI surgery, mean (SD), y | 56.9 (7.6) | 63.9 (10.4) | 64.1 (12.5) | 62.8 (11.1) |
| Visual analog scale quality of life score, mean (SD)c | 7.8 (2.5) | 9.6 (0.8) | 9.4 (0.9) | 9.2 (1.3) |
| Time until data saturation reached during focus group, min | 65 | 97 | 77 | NA |
Abbreviation: NA, not applicable.
a
Refers to use of a CI in one ear and a hearing aid in the other ear.
b
Refers to participants with preserved low-frequency hearing after cochlear implantation who use a combined hearing aid and CI device in the same ear; these individuals can be counted in more than 1 category, leading to count totals greater than 23.
c
On a scale of 1 to 10.